{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:03:13Z","timestamp":1787241793005,"version":"build-2736575974"},"reference-count":149,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.xagr.2024.100321","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T03:50:31Z","timestamp":1707450631000},"page":"100321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immunologic aspects of preeclampsia"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-1640","authenticated-orcid":false,"given":"Henri","family":"Boulanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bounan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Mahdhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Ahriz-Saksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Guimiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rouas-Freiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2024.100321_bib0001","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/14767050902784171","article-title":"Prenatal medicine: the child is the father of the man. 1996","volume":"22","author":"Romero","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0002","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/modpathol.2010.73","article-title":"The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth","volume":"23","author":"Kim","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.xagr.2024.100321_bib0003","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/aji.12141","article-title":"Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery","volume":"70","author":"Lee","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pd.5674","article-title":"Red cell alloimmunization: a 2020 update","volume":"40","author":"Castleman","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.xagr.2024.100321_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12235","article-title":"Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management","volume":"161","author":"Peterson","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.xagr.2024.100321_bib0006","first-page":"e15","article-title":"Fetal and neonatal alloimmune thrombocytopenia","volume":"6","author":"Espinoza","year":"2013","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0007","first-page":"227","article-title":"Neonatal alloimmune neutropenia: diagnosis and management of 31 Italian patients","volume":"21","author":"Cattaneo","year":"2023","journal-title":"Blood Transfus"},{"key":"10.1016\/j.xagr.2024.100321_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/iji.12514","article-title":"Human neutrophil antigens: nature, clinical significance and detection","volume":"48","author":"Browne","year":"2021","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.xagr.2024.100321_bib0009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1515\/jpm-2017-0073","article-title":"Fetal death: an extreme manifestation of maternal anti-fetal rejection","volume":"45","author":"Lannaman","year":"2017","journal-title":"J Perinat Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2559.2011.04038.x","article-title":"Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies","volume":"59","author":"Lee","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.xagr.2024.100321_bib0011","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajog.2021.06.051","article-title":"Chronic histiocytic intervillositis: manifestation of placental alloantibody-mediated rejection","volume":"225","author":"Benachi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semperi.2014.03.002","article-title":"Prediction and prevention of ischemic placental disease","volume":"38","author":"Friedman","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.xagr.2024.100321_bib0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0014","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0016","doi-asserted-by":"crossref","first-page":"S835","DOI":"10.1016\/j.ajog.2021.11.1371","article-title":"The evolution of the diagnostic criteria of preeclampsia-eclampsia","volume":"226","author":"Tanner","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1479-828X.2000.tb01137.x","article-title":"The detection, investigation and management of hypertension in pregnancy: full consensus statement","volume":"40","author":"Brown","year":"2000","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0018","first-page":"1122","article-title":"Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.xagr.2024.100321_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2024.100321_bib0021","first-page":"e1","article-title":"Gestational hypertension and preeclampsia. ACOG practice bulletin no. 202","volume":"133","year":"2019","journal-title":"Obstet Gynecol;"},{"key":"10.1016\/j.xagr.2024.100321_bib0022","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.xagr.2024.100321_bib0023","unstructured":"Hypertension in pregnancy: diagnosis and management. The National Institute for Health and Care Excellence (NICE). 2019. Available at:https:\/\/www.nice.org.uk\/guidance\/ng133\/resources\/hypertension-in-pregnancy-diagnosis-and-management-pdf-66141717671365. Accessed 9 September 2023."},{"key":"10.1016\/j.xagr.2024.100321_bib0024","first-page":"e1","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/AOG.0b013e3181801d56","article-title":"Prediction and prevention of recurrent preeclampsia","volume":"112","author":"Barton","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0026","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","volume":"226","author":"Staff","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0027","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/ajcp\/20.12.1099","article-title":"Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy","volume":"20","author":"Zeek","year":"1950","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.xagr.2024.100321_bib0028","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-0528.1972.tb12922.x","article-title":"On the pathogenesis of placental infarcts in pre-eclampsia","volume":"79","author":"Brosens","year":"1972","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.xagr.2024.100321_bib0029","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0031","doi-asserted-by":"crossref","first-page":"S1006","DOI":"10.1016\/j.ajog.2020.10.052","article-title":"Preeclampsia has two phenotypes which require different treatment strategies","volume":"226","author":"Masini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0032","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0033","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1\/PlGF ratio in singleton pregnancies","volume":"43","author":"Herraiz","year":"2018","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.xagr.2024.100321_bib0034","doi-asserted-by":"crossref","first-page":"S1048","DOI":"10.1016\/j.ajog.2020.09.046","article-title":"The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia","volume":"226","author":"Verlohren","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.xagr.2024.100321_bib0036","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0037","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pd.4403","article-title":"Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation","volume":"34","author":"Bujold","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.xagr.2024.100321_bib0038","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0039","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","article-title":"Subtypes of preeclampsia: recognition and determining clinical usefulness","volume":"77","author":"Roberts","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2024.100321_bib0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"Von Dadelszen","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.xagr.2024.100321_bib0041","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.xagr.2024.100321_bib0042","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/HYPERTENSIONAHA.114.04850","article-title":"Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension","volume":"65","author":"Veerbeek","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2024.100321_bib0043","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/uog.20126","article-title":"Metabolic syndrome and pre-eclampsia","volume":"54","author":"Hooijschuur","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4108271","article-title":"Early- and late-onset preeclampsia: a comprehensive cohort study of laboratory and clinical findings according to the new ISHHP criteria","volume":"2019","author":"W\u00f3jtowicz","year":"2019","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.xagr.2024.100321_bib0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1447-0756.2012.02010.x","article-title":"Risk factors of early and late onset pre-eclampsia","volume":"39","author":"Aksornphusitaphong","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.xagr.2024.100321_bib0046","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0047","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jri.2017.08.005","article-title":"Comparison of risk factors and perinatal outcomes in early onset and late onset preeclampsia: a cohort based study in Reunion Island","volume":"123","author":"Iacobelli","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0048","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/uog.17493","article-title":"Chronic hypertension and adverse pregnancy outcome: a cohort study","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0049","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/uog.17553","article-title":"Association of chronic hypertension with birth of small-for-gestational-age neonate","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/uog.17517","article-title":"Impaired placentation in women with chronic hypertension who develop pre-eclampsia","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0051","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ajog.2022.11.001","article-title":"Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood","volume":"228","author":"Chaiworapongsa","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0052","doi-asserted-by":"crossref","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","article-title":"The placenta and preeclampsia: villain or victim?","volume":"226","author":"Melchiorre","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0053","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0054","doi-asserted-by":"crossref","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2024.100321_bib0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1471-0528.1985.tb01064.x","article-title":"Pre-eclampsia in second pregnancy","volume":"92","author":"Campbell","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0056","doi-asserted-by":"crossref","first-page":"b2255","DOI":"10.1136\/bmj.b2255","article-title":"Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study","volume":"338","author":"Hern\u00e1ndez-D\u00edaz","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2024.100321_bib0057","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0028-2243(80)90051-9","article-title":"Pre-eclampsia and changed paternity","volume":"11","author":"Feeney","year":"1980","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.xagr.2024.100321_bib0058","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.281.6239.565-c","article-title":"Pre-eclampsia and eclampsia and change of paternity","volume":"281","author":"Scott","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.xagr.2024.100321_bib0059","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.316.7141.1343","article-title":"Fetal and maternal contributions to risk of pre-eclampsia: population based study","volume":"316","author":"Lie","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2024.100321_bib0060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.1.5957.548","article-title":"Pre-eclampsia in pregnancies by different fathers: immunological studies","volume":"1","author":"Need","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.xagr.2024.100321_bib0061","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.aje.a010122","article-title":"Changing paternity and the risk of preeclampsia\/eclampsia in the subsequent pregnancy","volume":"151","author":"Li","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.xagr.2024.100321_bib0062","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9378(77)90030-8","article-title":"Immunogestosis: a new etiologic concept of \u201dessential\u201d EPH gestosis, with special consideration of the primigravid patient; preliminary report of a clinical study","volume":"128","author":"Marti","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0063","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1001\/jama.1989.03430220066032","article-title":"An epidemiologic study of contraception and preeclampsia","volume":"262","author":"Klonoff-Cohen","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.xagr.2024.100321_bib0064","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(94)91638-1","article-title":"Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception","volume":"344","author":"Robillard","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.xagr.2024.100321_bib0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(96)91315-X","article-title":"Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception","volume":"347","author":"Robillard","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.xagr.2024.100321_bib0066","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa011379","article-title":"The interval between pregnancies and the risk of preeclampsia","volume":"346","author":"Skjaerven","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0067","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0165-0378(83)90242-5","article-title":"Pre-eclampsia in pregnancies from donor inseminations","volume":"5","author":"Need","year":"1983","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0068","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12884-021-03938-8","article-title":"Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses","volume":"21","author":"Chih","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.xagr.2024.100321_bib0069","first-page":"583","article-title":"Comparing maternal outcomes in spontaneous singleton pregnancies versus in vitro fertilization conception: single-center 10-year cohort study","volume":"26","author":"Singh","year":"2022","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.xagr.2024.100321_bib0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/09513590.2018.1528577","article-title":"Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study","volume":"35","author":"Rodriguez-Wallberg","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.xagr.2024.100321_bib0071","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/humrep\/deab267","article-title":"Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis","volume":"37","author":"Keukens","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2024.100321_bib0072","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/JPM.2005.004","article-title":"Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies","volume":"33","author":"Perni","year":"2005","journal-title":"J Perinat Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0073","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10815-016-0701-9","article-title":"Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis","volume":"33","author":"Bl\u00e1zquez","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.xagr.2024.100321_bib0074","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/14767058.2017.1309385","article-title":"Immunogenesis of preeclampsia: lessons from donor gametes","volume":"31","author":"Porreco","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajog.2009.02.030","article-title":"The developmental role of natural killer cells at the fetal-maternal interface","volume":"201","author":"Yagel","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0143-4004(03)00167-X","article-title":"The immunological paradox of pregnancy: a reappraisal","volume":"25","author":"Moffett","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.xagr.2024.100321_bib0077","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4049\/jimmunol.144.2.731","article-title":"Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule","volume":"144","author":"Ellis","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0078","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.xagr.2024.100321_bib0079","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0897.1990.tb00661.x","article-title":"Human trophoblast cells in culture express an unusual major histocompatibility complex class I-like antigen","volume":"23","author":"Grabowska","year":"1990","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0080","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M","article-title":"HLA-E is expressed on trophoblast and interacts with CD94\/NKG2 receptors on decidual NK cells","volume":"30","author":"King","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0081","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/plac.1999.0496","article-title":"Surface expression of HLA-C antigen by human extravillous trophoblast","volume":"21","author":"King","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.xagr.2024.100321_bib0082","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.144.8.3099","article-title":"Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy","volume":"144","author":"Holmes","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0083","doi-asserted-by":"crossref","first-page":"R381","DOI":"10.1016\/S0960-9822(00)00476-0","article-title":"Immunology of reproduction: protecting the placenta","volume":"10","author":"Morgan","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.xagr.2024.100321_bib0084","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/eji.1830220635","article-title":"Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55)","volume":"22","author":"Holmes","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0085","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.287.5452.498","article-title":"A critical role for murine complement regulator crry in fetomaternal tolerance","volume":"287","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.xagr.2024.100321_bib0086","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2005.06.017","article-title":"The complement system in the pathophysiology of pregnancy","volume":"43","author":"Girardi","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0087","doi-asserted-by":"crossref","first-page":"e12786","DOI":"10.1111\/aji.12786","article-title":"The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies","volume":"79","author":"Chang","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0088","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","article-title":"Indoleamine 2,3-dioxygenase and its therapeutic inhibition in cancer","volume":"336","author":"Prendergast","year":"2018","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.xagr.2024.100321_bib0089","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0090","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.xagr.2024.100321_bib0091","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/biomedicines10051065","article-title":"(Dis)similarities between the Decidual and Tumor Microenvironment","volume":"10","author":"Krstic","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.xagr.2024.100321_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.977618","article-title":"Three categories of similarities between the placenta and cancer that can aid cancer treatment: cells, the microenvironment, and metabolites","volume":"12","author":"Pang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.xagr.2024.100321_bib0093","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.162.10.6053","article-title":"TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege","volume":"162","author":"Phillips","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0094","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X","article-title":"Surface expression of TRAIL\/Apo-2 ligand in activated mouse T and B cells","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.280.5361.243","article-title":"Homeostasis and self-tolerance in the immune system: turning lymphocytes off","volume":"280","author":"Van Parijs","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.xagr.2024.100321_bib0096","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2017.01.009","article-title":"HLA-G: at the interface of maternal-fetal tolerance","volume":"38","author":"Ferreira","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0097","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3389\/fimmu.2019.00846","article-title":"Immune checkpoint molecules in reproductive immunology","volume":"10","author":"Miko","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0098","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/eji.201948382","article-title":"Immune checkpoint molecules in pregnancy: focus on regulatory T cells","volume":"50","author":"Zhang","year":"2020","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0099","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.4049\/jimmunol.0901154","article-title":"Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia","volume":"183","author":"Santner-Nanan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2007.03397.x","article-title":"Proportion of peripheral blood and decidual CD4+ CD25bright regulatory T cells in pre-eclampsia","volume":"149","author":"Sasaki","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0101","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fimmu.2019.00573","article-title":"New paradigm in the role of regulatory T cells during pregnancy","volume":"10","author":"Tsuda","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0102","doi-asserted-by":"crossref","first-page":"R884","DOI":"10.1152\/ajpregu.00154.2015","article-title":"An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia","volume":"309","author":"Cornelius","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.xagr.2024.100321_bib0103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/HYPERTENSIONAHA.118.10858","article-title":"Reduction in regulatory T cells in early pregnancy causes uterine artery dysfunction in mice","volume":"72","author":"Care","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2024.100321_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104125","article-title":"T cell immunity and the etiology and pathogenesis of preeclampsia","volume":"159","author":"Saito","year":"2023","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000527336","article-title":"Reconsideration of the role of regulatory T cells during pregnancy: differential characteristics of regulatory T cells between the maternal-fetal interface and peripheral sites and between early and late pregnancy","volume":"31","author":"Saito","year":"2022","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.xagr.2024.100321_bib0106","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3389\/fimmu.2020.01082","article-title":"Analysis of TCR repertoire and PD-1 expression in decidual and peripheral CD8+ T cells reveals distinct immune mechanisms in miscarriage and preeclampsia","volume":"11","author":"Morita","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0107","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molmed.2014.12.009","article-title":"Maternal uterine natural killer cells nurture fetal growth: in medio stat virtus","volume":"21","author":"Colucci","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0108","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ajog.2015.08.041","article-title":"Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0109","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.xagr.2024.100321_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1387\/ijdb.082763jb","article-title":"Immune cells in the placental bed","volume":"54","author":"Bulmer","year":"2010","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.xagr.2024.100321_bib0111","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3389\/fimmu.2019.02317","article-title":"Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface","volume":"10","author":"Yang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0112","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.xagr.2024.100321_bib0113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2012.05.031","article-title":"Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict","volume":"150","author":"Samstein","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xagr.2024.100321_bib0114","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gde.2017.08.004","article-title":"The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend","volume":"47","author":"Chavan","year":"2017","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.xagr.2024.100321_bib0115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nri1897","article-title":"Immunology of placentation in eutherian mammals","volume":"6","author":"Moffett","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12967-020-02371-3","article-title":"Decidual CD8+T cells exhibit both residency and tolerance signatures modulated by decidual stromal cells","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0117","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1073\/pnas.1713957115","article-title":"Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity","volume":"115","author":"Van der Zwan","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xagr.2024.100321_bib0118","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1098\/rstb.2011.0266","article-title":"Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules","volume":"367","author":"Parham","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.xagr.2024.100321_bib0119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.smim.2017.08.002","article-title":"Natural killer cell-mediated immunosurveillance of human cancer","volume":"31","author":"Malmberg","year":"2017","journal-title":"Semin Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0120","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3389\/fimmu.2019.01397","article-title":"Features of human decidual NK cells in healthy pregnancy and during viral infection","volume":"10","author":"Jabrane-Ferrat","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1293\/tox.2013-0060","article-title":"A comparison of the histological structure of the placenta in experimental animals","volume":"27","author":"Furukawa","year":"2014","journal-title":"J Toxicol Pathol"},{"key":"10.1016\/j.xagr.2024.100321_bib0122","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/imr.12323","article-title":"Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction","volume":"267","author":"Moffett","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.xagr.2024.100321_bib0123","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnana.2013.00022","article-title":"Maternal-fetal unit interactions and eutherian neocortical development and evolution","volume":"7","author":"Montiel","year":"2013","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.xagr.2024.100321_bib0124","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0126","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1084\/jem.20041214","article-title":"Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success","volume":"200","author":"Hiby","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0127","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0071","article-title":"The role of the maternal immune system in the regulation of human birthweight","volume":"370","author":"Moffett","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.xagr.2024.100321_bib0128","article-title":"The roles of uterine natural killer (NK) cells and KIR\/HLA-C combination in the development of preeclampsia: a systematic review","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.xagr.2024.100321_bib0129","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.274.5288.792","article-title":"Protection from natural killer cell-mediated lysis by HLA-G expression on target cells","volume":"274","author":"Pazmany","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.xagr.2024.100321_bib0130","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xagr.2024.100321_bib0131","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1158\/1078-0432.CCR-12-3697","article-title":"Molecular pathways: human leukocyte antigen G (HLA-G)","volume":"19","author":"Curigliano","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xagr.2024.100321_bib0132","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.humimm.2014.10.009","article-title":"A combination of single nucleotide polymorphisms in the 3\u2032untranslated region of HLA-G is associated with preeclampsia","volume":"75","author":"Quach","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0133","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.humimm.2021.01.003","article-title":"Role of the HLA-G immune checkpoint molecule in pregnancy","volume":"82","author":"Rouas-Freiss","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0134","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/molehr\/6.1.88","article-title":"Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia","volume":"6","author":"Goldman-Wohl","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.xagr.2024.100321_bib0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2004.01.033","article-title":"HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia","volume":"191","author":"Yie","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0136","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajog.2007.06.033","article-title":"Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia","volume":"197","author":"Hackmon","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0137","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0041-1345(01)02020-6","article-title":"A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity","volume":"33","author":"Marchal-Bras-Goncalves","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.xagr.2024.100321_bib0138","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/08820139.2018.1467925","article-title":"Association between HLA-G 14bp Gene polymorphism and serum sHLA-G protein concentrations in preeclamptic patients and normal pregnant women","volume":"47","author":"Rokhafrooz","year":"2018","journal-title":"Immunol Invest"},{"key":"10.1016\/j.xagr.2024.100321_bib0139","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/14767058.2013.818126","article-title":"Maternal Serum soluble HLA-G in complicated pregnancies","volume":"27","author":"B\u0131y\u0131k","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5603\/FHC.2012.0023","article-title":"The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia","volume":"50","author":"Darmochwal-Kolarz","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.xagr.2024.100321_bib0141","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1515\/jpm-2015-0062","article-title":"Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia","volume":"44","author":"He","year":"2016","journal-title":"J Perinat Med"},{"key":"10.1016\/j.xagr.2024.100321_bib0142","article-title":"Crosstalk between trophoblasts and decidual immune cells: the cornerstone of maternal-fetal immunotolerance","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0143","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.humimm.2021.02.013","article-title":"Contribution of macrophages to fetomaternal immunological tolerance","volume":"82","author":"Parasar","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.xagr.2024.100321_bib0144","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1089\/scd.2013.0079","article-title":"Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner","volume":"22","author":"Erkers","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.xagr.2024.100321_bib0145","doi-asserted-by":"crossref","first-page":"S886","DOI":"10.1016\/j.ajog.2020.09.039","article-title":"Decidualization resistance in the origin of preeclampsia","volume":"226","author":"Garrido-G\u00f3mez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2024.100321_bib0146","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/HYPERTENSIONAHA.114.04481","article-title":"Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia","volume":"65","author":"Rabaglino","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2024.100321_bib0147","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.placenta.2017.06.005","article-title":"Emerging role for dysregulated decidualization in the genesis of preeclampsia","volume":"60","author":"Conrad","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.xagr.2024.100321_bib0148","doi-asserted-by":"crossref","first-page":"E8468","DOI":"10.1073\/pnas.1706546114","article-title":"Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology","volume":"114","author":"Garrido-Gomez","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xagr.2024.100321_bib0149","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2019.11.1250","article-title":"Preeclampsia: a defect in decidualization is associated with deficiency of annexin A2","volume":"222","author":"Garrido-Gomez","year":"2020","journal-title":"Am J Obstet Gynecol"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577824000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577824000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:23:54Z","timestamp":1763000634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577824000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2666577824000157"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2024.100321","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic aspects of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2024.100321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100321"}}